Notice NOT-MH-19-037 from the NIH Guide for Grants and Contracts

With training in precision medicine, human genetics, predictive modeling, artificial intelligence, biomedical informatics, bioinformatics, or related field.
From Marshfield Clinic Health System - Wed, 07 Aug 2019 16:19:27 GMT - View all Marshfield, WI jobs

Negotiable: Paramount Recruitment: Data Scientist - Bioinformatics A world leader in innovative approaches to drug discovery, and global pharmaceutical company based in Cambridge is c Cambridge, England

Negotiable: Paramount Recruitment: Clinical Bioinformatician London To build on the success of the 100,000 Genomes Project, the Government tasked NHS England with support from Genomics London, England

Notice NOT-AT-19-031 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-20-044 from the NIH Guide for Grants and Contracts. This FOA invites applications on novel studies of the molecular mechanisms underlying metformins effects on aging and longevity. The goal of this FOA is to support applications that will lead to an in-depth understanding of the molecular mechanisms that determine the effects of metformin, either beneficial or detrimental, in relation to aging and longevity. Research supported by this FOA should lead to new insights and better understanding of metformins effects on aging and aging-related diseases.

Funding Opportunity RFA-HD-20-010 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage small businesses to collaborate with scientists and clinicians in the fields of female and male reproductive health, infertility, andrology, and/or gynecology to adapt discoveries in omics technologies such as genomics, epigenomics and metabolomics, as well as identification of disease biomarkers to the development of new devices, assays, digital apps, or technologies to improve the specificity of diagnosis and clinical care of infertility and to advance the application of precision medicine to reproductive health.

Funding Opportunity PAR-19-337 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit competitive revision (formerly known as competitive supplement) applications from awardees with active Clinical and Translational Science Award (CTSA) Program hub awards (UL1) to support the demonstration, and/or dissemination, and/or implementation of highly innovative and impactful translational science projects that address the goals of the CTSA Program and are beyond the original scope of the approved parent project.

Notice NOT-HL-19-715 from the NIH Guide for Grants and Contracts

competitive: University of Michigan Medical School: NIH T32-funded postdoctoral fellowships are available in the Department of Dermatology and affiliated departments.  Apply by Sept. 31. Ann Arbor, Michigan

Development of automated analysis methods to assess model quality and features, as well as the analysis of Molecular Dynamics simulations using statistical…
From Medical College of Wisconsin - Tue, 06 Aug 2019 21:07:39 GMT - View all Milwaukee, WI jobs

Notice NOT-OH-19-008 from the NIH Guide for Grants and Contracts

Notice NOT-OH-19-007 from the NIH Guide for Grants and Contracts

Notice NOT-AT-19-025 from the NIH Guide for Grants and Contracts

Notice NOT-NS-19-081 from the NIH Guide for Grants and Contracts

Adapts bioinformatic tools, visualization packages, and annotation resources for research projects to independently and accurately perform research analysis.
From Medical College of Wisconsin - Tue, 06 Aug 2019 15:07:30 GMT - View all Milwaukee, WI jobs

Competitive Salary: EMBL: Bio-IT Computational Support & Training Location: Germany (DE)

Competitive Salary: EMBL: Senior Software Engineer Location: Cambridge, Cambridgeshire, England

Not specified: CK Group: Natasha Young is currently recruiting for a Bioinformatician to join a dedicated team of researchers providing an outsourced service to Eli Lilly, one of the... Windlesham

Funding Opportunity PAR-19-328 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports applications to develop and implement investigator-initiated clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Clinical trials supported by this FOA include Phase II and above clinical trials. These trials may include ones that test different therapeutic, behavioral, and/or prevention strategies. Trials for which this FOA applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website. This FOA will utilize a bi-phasic, milestone-driven mechanism of award. It is anticipated that applications will present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes the conduct of the trial, as well as plans for project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. The multiple PD/PI model is strongly encouraged but not required. Applicants are encouraged to include a PD/PI with expertise in biostatistics, clinical trial design, and coordination. Due to the complex nature of conducting a clinical trial, applicants are strongly encouraged to contact the appropriate Scientific/Research contact prior to submitting an application. Staff will be able to assist applicants in meeting the objectives of this FOA.